GoodRx vs PlushCare
GoodRx and PlushCare both sell tirzepatide; this is how their prices, coverage and records differ.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
PlushCare
Best for: coverage in all 50 states, which most sellers will not confirm
Visit PlushCare →If you are choosing between GoodRx and PlushCare, price alone will not settle it. Both prescribe tirzepatide, so moving from one to the other would not change your drug. GoodRx leads our six-part score, 6.9 to 6.4.
GoodRx vs PlushCare price
GoodRx and PlushCare start at the same figure, $149 a month, so the entry price does not separate them. Look at what each price covers and at the per-drug prices below.
Drug by drug: Tirzepatide is cheaper at GoodRx ($299 a month vs $399 a month).
Medications and formats
Both sell tirzepatide; only GoodRx lists orforglipron; only PlushCare lists semaglutide.
On format, GoodRx prices brand-name pens, while PlushCare prices compounded injections.
If you want the FDA-approved brand rather than a compounded version, GoodRx is the only one of the two with a brand-name price.
Where each one treats patients
GoodRx lists 50 states, and PlushCare lists 50 states.
They overlap in 50 states.
Pricing
GoodRx
PlushCare
Range up to $299/mo
Range up to $599/mo
What each price covers
GoodRx does not say what its price includes.
PlushCare is silent on shipping and coaching.
GoodRx
Inclusions not disclosed.
PlushCare
Covered by the monthly price
Medication
Charged on top
Clinician visits
Charged on top
Shipping
Not stated
Lab work
Charged on top
Coaching
Not stated
Where each one scores higher
Overall, GoodRx scores 6.9 and PlushCare 6.4 out of 10.
GoodRx is stronger on value (5.0 vs 3.0) and support (5.0 vs 0.0).
PlushCare is stronger on user experience (7.0 vs 5.0) and trust & safety (7.5 vs 6.0).
Effectiveness and accessibility are within half a point.
GoodRx
6.9/10
PlushCare
6.4/10
Value25%
Effectiveness25%
User Experience15%
Trust & Safety15%
Accessibility10%
Support10%
FDA warning letters
Neither GoodRx nor PlushCare has an FDA warning letter on record with us.
Features & Coverage
| Feature | GoodRx | PlushCare |
|---|---|---|
| Starting Price | $149/mo | $149/mo |
| Features | 6 features | ✓8 features |
| States Available | 50 | 50 |
| Compounded | — | ✓ Yes |
| Brand Name | ✓ Yes | — |
| FSA/HSA Accepted | — | — |
| FDA Warning Letters | None | None |
About GoodRx
GoodRx (NASDAQ: GDRX) is the largest US prescription savings platform. It publishes self-pay discount pricing on brand-name GLP-1 medications, with Foundayo (orforglipron) starting at $149/month and the Zepbound KwikPen (tirzepatide) starting at $299/month, redeemable at 70,000+ pharmacies nationwide. It also operates GoodRx Care, a telehealth arm that prescribes GLP-1s with online visits starting at $39.
Read our full GoodRx review →About PlushCare
PlushCare is an established virtual primary-care telehealth platform and a subsidiary of Transcarent, Inc., a Delaware corporation that also owns Accolade, 2nd.MD, and 98point6 by Transcarent. Virtual visits with US board-certified physicians cost $30 per appointment insured and $129 self-pay. GLP-1 prescribing is a clinician-discretionary option within the broader primary-care relationship.
Read our full PlushCare review →Pros & Cons
GoodRx
What we like
- Orforglipron costs $149 a month, close to the $149 median for brand-name orforglipron across the sellers we compare
- Tirzepatide costs $299 a month, 76% below the $1249 median for brand-name tirzepatide across the sellers we compare
- Serves all 50 states
- We found no FDA warning letters issued to GoodRx
Watch-outs
- Ask which pharmacy fills the prescription before you pay, so you can check its license
PlushCare
What we like
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- Serves all 50 states
- We found no FDA warning letters issued to PlushCare
- A live video visit with a clinician is required before a prescription, which is slower than a form and is the more careful intake
- Baseline bloodwork is required before a prescription
Watch-outs
- Not included in the monthly price: medication, clinician visits, lab work
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
Our Verdict
GoodRx wins this one, 6.9 to 6.4, above all for oral orforglipron alongside the injectables. PlushCare fits better if coverage in all 50 states, which most sellers will not confirm is your priority.
Choose GoodRx if…
You want oral orforglipron alongside the injectables and an opening price near $149 a month.
Choose PlushCare if…
You want coverage in all 50 states, which most sellers will not confirm and an opening price near $149 a month.
Ready to start? GLP-1 providers we have vetted
Telehealth providers, vetted by us, prescribing GLP-1 online.
Vetted by our editors · no insurance required
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Wellorithm
Compounded semaglutide at $247/month
From $247/mo
Get started →Willow
Seeing what it charges before you answer any medical questions
From $299/mo
Get started →Sesame Care
Oral orforglipron alongside the injectables
From $59/mo
Get started →GoodRx vs PlushCare: FAQ
Close alternatives to GoodRx and PlushCare
- GoodRx vs Found
- GoodRx vs Kin Meds
- GoodRx vs PrideRx
- GoodRx vs PreventiveMD
- PlushCare vs altRX
- PlushCare vs Trinity Meds
Or see the full category ranking.
Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.